[Pharmacoeconomic analysis of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy for the secondary prevention of coronary heart disease].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples